Enzymatic diagnostic test for muscle-eye-brain type congenital muscular dystrophy using commercially available reagents
W Zhang, J Vajsar, P Cao, G Breningstall, C Diesen… - Clinical …, 2003 - Elsevier
W Zhang, J Vajsar, P Cao, G Breningstall, C Diesen, W Dobyns, R Herrmann, AE Lehesjoki…
Clinical biochemistry, 2003•ElsevierOBJECTIVES: Mutations disrupting the interaction of extra-cellular ligands and α-
dystroglycan are responsible for an etiologically heterogeneous group of autosomal
recessive congenital muscular dystrophies (CMD) that can have associated brain and eye
abnormalities. The objective is to develop a diagnostic test for one of these CMDs, Muscle-
Eye-Brain disease (MEB), due to mutations in the gene encoding Protein O-Mannosyl β-1, 2-
N-acetylglucosaminyltransferase 1 (POMGnT1). DESIGN AND METHODS: POMGnT1 …
dystroglycan are responsible for an etiologically heterogeneous group of autosomal
recessive congenital muscular dystrophies (CMD) that can have associated brain and eye
abnormalities. The objective is to develop a diagnostic test for one of these CMDs, Muscle-
Eye-Brain disease (MEB), due to mutations in the gene encoding Protein O-Mannosyl β-1, 2-
N-acetylglucosaminyltransferase 1 (POMGnT1). DESIGN AND METHODS: POMGnT1 …
OBJECTIVES
Mutations disrupting the interaction of extra-cellular ligands and α-dystroglycan are responsible for an etiologically heterogeneous group of autosomal recessive congenital muscular dystrophies (CMD) that can have associated brain and eye abnormalities. The objective is to develop a diagnostic test for one of these CMDs, Muscle-Eye-Brain disease (MEB), due to mutations in the gene encoding Protein O-Mannosyl β-1,2-N-acetylglucosaminyltransferase 1 (POMGnT1).
DESIGN AND METHODS
POMGnT1 enzyme activity was determined in extracts of muscle biopsies from four MEB patients and various controls using commercially available reagents.
RESULTS
All four MEB muscle samples showed a highly significant decrease in POMGnT1 activity relative to controls.
CONCLUSIONS
The assay of POMGnT1 activity in MEB muscle provides a rapid and relatively simple diagnostic test for this disease. CMDs associated with brain malformations such as MEB, WWS and FCMD are heterogenous in clinical presentation and on radiologic examination, suggesting that POMGnT1 assays of muscle biopsies should be used as a screening procedure for MEB in all CMD patients associated with brain malformations.
Elsevier